phase readout
saveNCT02583893: Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. Phase: PHASE2. Conditions: Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
view source ↗
comments(0)
5-min edit window · permanent after that